Explore the full record of transactions filed by Kelly John Alexander, Chief Financial Officer. Director active across 1 companies, notably Precision Biosciences INC. Aggregated, 6 disclosures have been recorded. Total volume traded: €95k. The latest transaction was disclosed on 22 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
John Alexander Kelly is the Chief Financial Officer of Precision Biosciences Inc. He oversees the financial management of the company, including budgeting and financial reporting, thereby contributing to the financial health of the company.